PL365896A1 - Sposoby oczyszczania i odzyskiwania białka - Google Patents

Sposoby oczyszczania i odzyskiwania białka

Info

Publication number
PL365896A1
PL365896A1 PL01365896A PL36589601A PL365896A1 PL 365896 A1 PL365896 A1 PL 365896A1 PL 01365896 A PL01365896 A PL 01365896A PL 36589601 A PL36589601 A PL 36589601A PL 365896 A1 PL365896 A1 PL 365896A1
Authority
PL
Poland
Prior art keywords
ifn
recovery
methods
renaturation
protein purification
Prior art date
Application number
PL01365896A
Other languages
English (en)
Other versions
PL206428B1 (pl
Inventor
Sid Wolfe
Irina Esikova
Susan Babuka
Bret A. Shirley
Dennis Fordham
Original Assignee
Chiron Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corporation filed Critical Chiron Corporation
Publication of PL365896A1 publication Critical patent/PL365896A1/pl
Publication of PL206428B1 publication Critical patent/PL206428B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL365896A 2000-10-27 2001-10-26 Sposób otrzymywania kompozycji zawierającej interferon beta (IFN-β) PL206428B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24396500P 2000-10-27 2000-10-27
US28260701P 2001-04-09 2001-04-09
US33037501P 2001-10-18 2001-10-18
US10/035,420 US7544354B2 (en) 2000-10-27 2001-10-25 Methods of protein purification and recovery

Publications (2)

Publication Number Publication Date
PL365896A1 true PL365896A1 (pl) 2005-01-10
PL206428B1 PL206428B1 (pl) 2010-08-31

Family

ID=27488301

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365896A PL206428B1 (pl) 2000-10-27 2001-10-26 Sposób otrzymywania kompozycji zawierającej interferon beta (IFN-β)

Country Status (16)

Country Link
US (3) US7544354B2 (pl)
EP (1) EP1366060B1 (pl)
JP (1) JP3946139B2 (pl)
CN (1) CN100493601C (pl)
AT (1) ATE383368T1 (pl)
AU (1) AU2002234161B2 (pl)
BG (1) BG66119B1 (pl)
CA (1) CA2427088C (pl)
CZ (1) CZ301360B6 (pl)
DE (1) DE60132366T2 (pl)
ES (1) ES2299528T3 (pl)
IL (1) IL155577A0 (pl)
NO (1) NO326288B1 (pl)
PL (1) PL206428B1 (pl)
PT (1) PT1366060E (pl)
WO (1) WO2002034791A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544354B2 (en) * 2000-10-27 2009-06-09 Novartis Vaccines And Diagnostics Methods of protein purification and recovery
US20060035327A1 (en) * 2001-02-28 2006-02-16 Guangwen Wei Recombinant super-compound interferon and uses thereof
US20050079579A1 (en) * 2001-02-28 2005-04-14 Guangwen Wei Uses of spatial configuration to modulate protein function
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
US20050029194A1 (en) * 2003-08-07 2005-02-10 Hall David Bruce Method for removal of guanidine compound from aqueous media
US7585647B2 (en) * 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
TWI380993B (zh) * 2005-03-09 2013-01-01 輝陽科技美國公司 重組型超化合物干擾素之用途
US20090247421A1 (en) * 2005-03-23 2009-10-01 Egisto Boschetti Diverse chemical libraries bound to small particles with paramagnetic properties
CA2602951A1 (en) * 2005-03-23 2006-09-28 Bio-Rad Laboratories, Inc. Diverse chemical libraries bound to small particles with paramagnetic properties
AU2006275800A1 (en) * 2005-07-29 2007-02-08 Novartis Ag Method and system for in vitro protein folding
JP2007126391A (ja) * 2005-11-02 2007-05-24 Sanyo Chem Ind Ltd タンパク質のリフォールディング剤
WO2007020886A1 (ja) 2005-08-16 2007-02-22 Sanyo Chemical Industries, Ltd. タンパク質のリフォールディング剤およびリフォールディング方法
JP4786303B2 (ja) * 2005-11-02 2011-10-05 三洋化成工業株式会社 タンパク質のリフォールディング剤
JP5274795B2 (ja) * 2006-07-27 2013-08-28 三洋化成工業株式会社 タンパク質のリフォールディング方法
CN101675071B (zh) 2007-05-02 2014-06-18 Ambrx公司 经修饰干扰素β多肽和其用途
EP2207890A4 (en) * 2007-10-05 2010-12-15 Barofold Inc HIGH PRESSURE PROCESSING OF AGGREGATED INTERFERONS
KR101113495B1 (ko) 2008-01-23 2012-02-29 한미홀딩스 주식회사 인간 인터페론 베타의 정제방법
GB0821010D0 (en) * 2008-11-17 2008-12-24 Univ Warwick Plant development control composition
CN101885767B (zh) * 2010-06-13 2013-03-13 深圳科兴生物工程有限公司 一种取代单克隆抗体亲和层析的分离纯化重组人干扰素α1b的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US5702699A (en) 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4462940A (en) 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4992271A (en) 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4816440A (en) 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
CA1294215C (en) 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US4894330A (en) 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US4931543A (en) 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
CA1340586C (en) 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
KR930006706B1 (ko) 1991-04-29 1993-07-23 주식회사 럭키 인간 인터페론 베타의 정제방법
DE4407325B4 (de) * 1994-03-04 2006-06-29 Basf Ag Verfahren zur Herstellung von 3-Aminomethyl-3,5,5-trimethylcyclohexylamin
AU696387B2 (en) 1994-05-18 1998-09-10 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
US5814485A (en) * 1995-06-06 1998-09-29 Chiron Corporation Production of interferon-β (IFN-β) in E. coli
BR9606270A (pt) 1996-12-18 1998-09-22 Univ Minas Gerais Processo para a produção da proteína do interferon beta-cis humano recombinante e proteína de interferon beta-cis humano recombinante
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7544354B2 (en) * 2000-10-27 2009-06-09 Novartis Vaccines And Diagnostics Methods of protein purification and recovery
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta

Also Published As

Publication number Publication date
DE60132366D1 (de) 2008-02-21
PT1366060E (pt) 2008-03-17
US20040115169A1 (en) 2004-06-17
IL155577A0 (en) 2003-11-23
CZ20031157A3 (en) 2004-03-17
CZ301360B6 (cs) 2010-01-27
JP2004512343A (ja) 2004-04-22
NO20031839L (no) 2003-05-28
EP1366060A2 (en) 2003-12-03
CA2427088A1 (en) 2002-05-02
US20090123424A1 (en) 2009-05-14
BG66119B1 (bg) 2011-05-31
AU2002234161B2 (en) 2006-10-19
CN1479627A (zh) 2004-03-03
JP3946139B2 (ja) 2007-07-18
EP1366060B1 (en) 2008-01-09
US20020137895A1 (en) 2002-09-26
CN100493601C (zh) 2009-06-03
BG107844A (bg) 2004-07-30
US7544354B2 (en) 2009-06-09
WO2002034791A2 (en) 2002-05-02
ES2299528T3 (es) 2008-06-01
DE60132366T2 (de) 2009-01-29
NO326288B1 (no) 2008-11-03
CA2427088C (en) 2011-06-21
US8388942B2 (en) 2013-03-05
WO2002034791A3 (en) 2003-10-09
ATE383368T1 (de) 2008-01-15
NO20031839D0 (no) 2003-04-24
PL206428B1 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
IL155577A0 (en) Methods of protein purification and recovery
DE59904569D1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
WO2001007432A8 (en) Aminopiperidine derivatives as antibacterials
YU50502A (sh) Postupak za prečišćavanje farmakološki aktivnih proteina pomoću katjonske izmenjivačke hromatografije
CA2446619A1 (en) Permeation enhancers
WO1995025749A3 (en) Eating suppressant peptides
CY1113609T1 (el) ΔΙΑΛΥΤΟΤΗΤΑ ΙFΝ-ΒΗΤΑ-1b ΣΕ ΔΙΑΛΥΜΑΤΑ ΧΛΩΡΙΟΥΧΟΥ ΝΑΤΡΙΟΥ
DE60034707D1 (de) Allgemeines verfahren zur rückfaltung rekombinanter proteine
EP0528312A3 (en) Cyclic peptides and use thereof
JP2005502595A5 (pl)
GR3023717T3 (en) Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
PL350135A1 (en) Process for purifying high molecular weight hyaluronic acid
JP2006527185A5 (pl)
JP2007526317A5 (pl)
CA1273592C (en) ISOLATION OF A BIOACTIVE MONOMER GROWTH HORMONE
SG152048A1 (en) A process for the extraction, purification and enzymatic modification of soy 7s globulin alphaæ subunit foruse as hypocholesterolemizing agent
JP2004538275A5 (pl)
EA200200743A1 (ru) Рекомбинантное ослабление вируса репродуктивного и респираторного синдрома свиней (prrsv)
IL78455A (en) Method for purifying recombinant human immune interferon
NO983054L (no) Virale rekombinante pseudopartikler og anvendelse som vaksiner og som anti-tumormiddel
ATE353669T1 (de) Allergievakzine sowie ihre herstellung
DE60027581D1 (de) Design von immunogene
NZ516235A (en) Method for purification of proteins
SE9600791L (sv) Metod för eradikering av Helicobacter pylori infektion
WO2001049720A3 (fr) Glycoproteine d'enveloppe du vih modifiee chimiquement